Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 80.00 | |
5 mg | In stock | $ 392.00 | |
10 mg | In stock | $ 668.00 | |
25 mg | In stock | $ 1,460.00 | |
50 mg | In stock | $ 1,980.00 |
Description | BTA-9881 is a novel RSV fusion inhibitor with oral activity and antiviral activity for the study of respiratory syncytial virus infections. |
Synonyms | BTA9881, AZD9639, AZD-9639, BTA 9881, MEDI-564 |
Molecular Weight | 390.82 |
Formula | C21H15ClN4O2 |
CAS No. | 1646857-24-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BTA-9881 1646857-24-0 Microbiology/Virology RSV BTA9881 AZD9639 AZD-9639 BTA 9881 MEDI564 AZD 9639 MEDI 564 MEDI-564 inhibitor inhibit